×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
The Evolving Role of Artificial Intelligence in the Medicinal Product Lifecycle
Session Chair(s)
Hilmar Hamann, PhD
Head of Information Management
European Medicines Agency, Netherlands
This session will provide perspectives from stakeholders on successes and limitations from practical examples and discuss principles and best practices for maximizing the potential while managing the risks moving forward.
Learning Objective : Describe the current state of the use of artificial intelligence (AI) in the medicinal product lifecycle including its opportunities and challenges; Discuss principles and best practices to maximize potential of AI while managing risks.
Speaker(s)
EMA Update
Lorenzo De Angelis, PhD
European Medicines Agency, Netherlands
Platform Architect
Industry Update
Carlyn Crisostomo, MBA
Amgen, United States
Vice President, Head of Technology Innovation, Amgen
Industry Update
Alexandra (Zan) Cha, PhD, MA
Booz Allen Hamilton, United States
Principal, Chief Technology Office
Industry Update
Timothe Menard, PharmD, MSc
F. Hoffmann-La Roche Ltd, Switzerland
Global Head, Quality Excellence Digital | Bioethics Coach (Data Ethics)
Have an account?